SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-24-000037
Filing Date
2024-05-07
Accepted
2024-05-07 16:09:58
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20240331.htm   iXBRL 10-Q 1169771
2 EX-31.1 ex31110qq120234.htm EX-31.1 12953
3 EX-31.2 ex31210qq12024.htm EX-31.2 12892
4 EX-32 ex3210qq12024.htm EX-32 13875
10 GRAPHIC halo-20240331_g1.jpg GRAPHIC 15840
11 GRAPHIC halo-20240331_g2.jpg GRAPHIC 150214
12 halo-20240331_g3.jpg GRAPHIC 85012
  Complete submission text file 0001159036-24-000037.txt   8119903

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20240331.xsd EX-101.SCH 48313
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20240331_cal.xml EX-101.CAL 77207
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20240331_def.xml EX-101.DEF 266981
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20240331_lab.xml EX-101.LAB 650899
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20240331_pre.xml EX-101.PRE 461768
86 EXTRACTED XBRL INSTANCE DOCUMENT halo-20240331_htm.xml XML 1148565
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 24921902
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)